Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sharps Technology, Inc. ( (STSS) ) just unveiled an announcement.
On April 30, 2025, Sharps Technology announced the receipt of a $400,000 purchase order from a U.S. leader in IV flushing solutions, marking the first commercial revenue under a $50 million supply agreement. This milestone order initiates a five-year contract to supply approximately 500 million customized 10mL SoloGard syringes, with Sharps investing in advanced production technology to meet the growing demand and enhance manufacturing efficiency.
More about Sharps Technology, Inc.
Sharps Technology is an innovative medical device and pharmaceutical packaging company specializing in patented smart-safety syringe products. The company focuses on providing ultra-low waste capabilities with syringes that incorporate both passive and active safety features, and it also supports the prefillable syringe market segment with specialized copolymer technology. Sharps Technology operates a manufacturing facility in Hungary.
YTD Price Performance: -99.08%
Average Trading Volume: 365,299
Technical Sentiment Signal: Buy
Current Market Cap: $309.3K
Find detailed analytics on STSS stock on TipRanks’ Stock Analysis page.